MRUS Merus N.V.

13.66
+0.1  (+1%)
Previous Close 13.56
Open 13.84
Price To Book 3.11
Market Cap 319083626
Shares 23,358,977
Volume 104,673
Short Ratio
Av. Daily Volume 29,289

NewsSee all news

  1. Merus to Present at the RBC Capital Markets 2019 Healthcare Conference
  2. Agios' Tibsovo Meets Endpoint in Cholangiocarcinoma Study
  3. Mallinckrodt Ends Enrollment in Phase III for Terlipressin
  4. Tilray (TLRY) to Report Q1 Earnings: What's in the Cards?
  5. Merus Announces First Patient Treated in Phase 1 Clinical Trial of MCLA-145 for Advanced Solid Tumors

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 update due 2H 2019.
MCLA-128
Breast cancer - HER2-positive MBC and ER+/HER2-low MBC
Noted December 27, 2018 that NSCLC cohort enrolment is ongoing but will discontinue endometrial and ovarian cohorts.
MCLA-128
Gastric cancer, non-small cell lung cancer
Phase 1 initial data due 2H 2019.
MCLA-117
Acute Myeloid Leukemia
Phase 1 emerging data due YE 2019.
MCLA-158
Colorectal cancer
Phase 1 dosing has commenced - May 9, 2019.
MCLA-145
Solid tumors

Latest News

  1. Merus to Present at the RBC Capital Markets 2019 Healthcare Conference
  2. Agios' Tibsovo Meets Endpoint in Cholangiocarcinoma Study
  3. Mallinckrodt Ends Enrollment in Phase III for Terlipressin
  4. Tilray (TLRY) to Report Q1 Earnings: What's in the Cards?
  5. Merus Announces First Patient Treated in Phase 1 Clinical Trial of MCLA-145 for Advanced Solid Tumors
  6. Evoke Pharma (EVOK) to Post Q1 Earnings: What's in Store?
  7. Agios (AGIO) Earnings and Revenues Surpass Estimates in Q1
  8. Acorda (ACOR) Earnings and Revenues Beat Estimates in Q1
  9. Vertex (VRTX) Q1 Earnings and Revenues Surpass Estimates
  10. BioMarin (BMRN) Shares Down Despite Q1 Earnings & Sales Beat
  11. Kamada to Begin Phase III Study for Inhaled AAT Product in 2H
  12. Fibrocell Out-licenses Skin Disease Gene Therapy, Stock Rises
  13. Mallinckrodt (MNK) Completes Enrollment in Skin Tissue Study
  14. Will Merus Continue to Surge Higher?
  15. Merus Announces Financial Results for the Full Year 2018 and Provides Business Update
  16. Merus and Incyte Present MCLA-145 Program Preclinical Data at the AACR Annual Meeting 2019
  17. Merus to Present at the Cowen & Co. 39th Annual Health Care Conference
  18. Merus to Participate in Guggenheim Healthcare Talks Idea Forum
  19. Vertex's Kalydeco Wins Health Canada Nod to Treat CF in Kids